BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14616398)

  • 1. A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate.
    Sakuma-Oyama Y; Nishibu A; Oyama N; Saito M; Nakamura K; Kaneko F
    Br J Dermatol; 2003 Oct; 149(4):901-3. PubMed ID: 14616398
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
    Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
    J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
    [No Abstract]   [Full Text] [Related]  

  • 3. Kimura's disease treated with suplatast tosilate and loratadine.
    Ueda T; Arai S; Amoh Y; Katsuoka K
    Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
    [No Abstract]   [Full Text] [Related]  

  • 4. Suplatast tosilate for treating cutaneous mastocytosis.
    Yasudo H; Ando T; Hiwatari M; Oka A
    Pediatr Dermatol; 2015; 32(3):e118-9. PubMed ID: 25779849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
    Hashizume H; Umayahara T
    Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
    Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of chronic eosinophilic pneumonia with suplatast tosilate].
    Kusumoto H; Mizuno K; Yonemaru M; Nakano M; Ichinose Y; Toyama K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):550-4. PubMed ID: 9234634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cough-variant asthma successfully treated with suplatast tosilate].
    Fujimori K; Suzuki E; Arakawa M
    Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of suplatast tosilate in a case of recurrent eosinophilic annular erythema.
    Kanameishi S; Goto K; Ogawa M; Fukumoto T; Tanabe H
    Int J Dermatol; 2018 Sep; 57(9):e66-e68. PubMed ID: 29655235
    [No Abstract]   [Full Text] [Related]  

  • 10. Case 36-2007: a woman with rash, fever, and hypotension.
    Mir MA; Khalil F
    N Engl J Med; 2008 Mar; 358(13):1406; author reply 1406-7. PubMed ID: 18376447
    [No Abstract]   [Full Text] [Related]  

  • 11. Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate.
    Teraki Y; Fukuda T
    Br J Dermatol; 2008 Feb; 158(2):424-6. PubMed ID: 18047503
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
    Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
    J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suplatast tosilate dimethylsulfonium treatment for steroid-dependent nephrotic syndrome.
    Ohtomo Y; Fujinaga S; Hattori M
    Pediatr Int; 2005 Apr; 47(2):230-1. PubMed ID: 15771702
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case report of eosinophilic cystitis treated with oral suplatast tosilate].
    Kuramoto T; Senzaki H; Inagaki T
    Hinyokika Kiyo; 2014 Sep; 60(9):447-50. PubMed ID: 25293800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
    Yamada Y; Yoshihara S; Arisaka O
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
    [No Abstract]   [Full Text] [Related]  

  • 18. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
    Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study.
    Miyachi Y; Katayama I; Furue M
    Allergol Int; 2007 Sep; 56(3):269-75. PubMed ID: 17582208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
    Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
    J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.